Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Nano-X Imaging Ltd.NASDAQ: NNOX

Weighted Avg Shares (Diluted) · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares (diluted) grows in line with its trailing trend

Q4 FY2025 weighted avg shares (diluted) of 67.06M shares rose 11.5% year over year, ahead of the +10.5% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at +7.4% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +11.5% holds above the trailing-twelve-month pace of +10.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
67.06M+4.3% QoQ
Last fiscal yearDec 2025
64.79M+10.5% YoY
LTMDec 2025
64.81M+10.5% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.5%——
1 year+10.5%——
3-year CAGR+7.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
64.79M USD
Year-over-year change
+10.5%
4-year CAGR
+7.7%

Weighted Avg Shares (Diluted) vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 weighted avg shares (diluted) of 64.81M shares is the 3rd highest of the 11 companies compared; the peer median is 37.79M shares.
  • Its year-over-year change of +10.5% is the 9th highest of 11, against a peer median of +18.6%.
  • Over three fiscal years its annual growth of +7.4% compares with a peer median of +9.6%.
NNOX Competitors Peer median
Weighted Avg Shares (Diluted) for NNOX and competitors
Company Period LTM YoY 3-year CAGR
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
HCATHealth Catalyst, Inc.LTM Mar 202670.9M +13.1%+8.9%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.78M +66.1%+8.6%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
Peer median (excluding NNOX) 37.79M+18.6%+9.6%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.